Drug profile · INN
phenindione
HEDULIN
phenindione (HEDULIN) is a vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — phenindione
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
phenindione (HEDULIN) is a vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor
Primary target: Vitamin K epoxide reductase complex subunit 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is phenindione?
phenindione (HEDULIN) is a vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for phenindione?
HEDULIN is a marketed brand name for phenindione. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of phenindione?
phenindione has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.